STOCK TITAN

Ingersoll Rand (IR) Stock News, Feb-May 2024

IR NYSE

Ingersoll Rand Inc. reports developments tied to its mission-critical flow creation, life science and industrial solutions portfolio. Company news commonly covers operating results, order and revenue trends, segment performance, and regular capital-return actions such as cash dividends.

Updates also include bolt-on acquisitions that expand technologies within areas such as metering and dosing, compression, blower and vacuum, and fluid management. Recent acquisition activity added hydropneumatic accumulators, pulsation dampeners, calibration pots and instrumentation to the Precision and Science Technologies segment. Other recurring announcements address sustainability recognition, investor conference participation, governance matters and business outlook commentary.

Rhea-AI Summary

Ingersoll Rand has led a $19M financing round for Inkbit, a pioneer in advanced additive manufacturing solutions. The funding will advance Inkbit's Vision-Controlled Jetting™ (VCJ) technology, enabling rapid manufacturing of innovative products like complex industrial fluidics and bio-inspired robots. Inkbit's technology reimagines the traditional assembly line, combining scalability, reliability, and intelligence to build multi-functional products in one pass.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.03%
Tags
none
-
Rhea-AI Summary

Ingersoll Rand reported record first quarter revenues, Adjusted EBITDA, and Adjusted EPS. The company raised its total company Adjusted EBITDA and Adjusted EPS guidance for 2024, showcasing a strong performance driven by Ingersoll Rand Execution Excellence (IRX). Despite a decline in orders, the two-year stack shows an improvement, with reported revenues and net income also on the rise. The company maintains a healthy liquidity of $3.5 billion and has raised its 2024 guidance for Adjusted EBITDA and Adjusted EPS. Ingersoll Rand is focused on delivering long-term value to shareholders through strategic acquisitions and comprehensive capital allocation strategies.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.60%
Tags
-
Rhea-AI Summary

Ultima Genomics, a developer of an innovative ultra-high throughput sequencing architecture, announced the addition of Mark Stevenson, a seasoned executive with over 30 years of experience in the life sciences sector, to its Board of Directors. Stevenson, the former Executive Vice President and COO of Thermo Fisher Scientific, brings valuable expertise in next-generation sequencing technologies and innovation. His appointment is expected to bolster Ultima Genomics' position in the genomics and healthcare fields.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.16%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.60%
Tags
buybacks dividends
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.55%
Tags
conferences earnings
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.91%
Tags
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.72%
Tags
conferences
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.33%
Tags
conferences
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.54%
Tags
dividends

FAQ

What is the current stock price of Ingersoll Rand (IR)?

Ingersoll Rand (IR) last closed at $82.60.

What is the market cap of Ingersoll Rand (IR)?

The market cap of Ingersoll Rand (IR) is approximately $31.7B.